Difference between revisions of "Pentamidine (Nebupent)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "Category:Inhaled" to "Category:Inhalation")
m (Text replacement - "http://hemonc.org" to "https://hemonc.org")
(One intermediate revision by the same user not shown)
Line 1: Line 1:
 
==General information==
 
==General information==
Class/mechanism: Antifungal, known to have activity against Pneumocystis jiroveci.  Mechanism not fully understood, but mechanism hypothesized to involve inhibition of DNA, RNA, phospholipid, and protein synthesis.<ref name="insert">[http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf Pentamidine (Nebupent) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/pentamidine.pdf Pentamidine (Nebupent) package insert (locally hosted backup)]</ref>
+
Class/mechanism: Antifungal, known to have activity against Pneumocystis jiroveci.  Mechanism not fully understood, but mechanism hypothesized to involve inhibition of DNA, RNA, phospholipid, and protein synthesis.<ref name="insert">[http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019887s014lbl.pdf Pentamidine (Nebupent) package insert]</ref><ref>[https://hemonc.org/docs/packageinsert/pentamidine.pdf Pentamidine (Nebupent) package insert (locally hosted backup)]</ref>
 
<br>Route: inhaled, IM, IV
 
<br>Route: inhaled, IM, IV
 
<br>Extravasation: no information
 
<br>Extravasation: no information
Line 21: Line 21:
 
[[Category:PCP prophylaxis]]
 
[[Category:PCP prophylaxis]]
  
[[Category:Drugs FDA approved in 1989]]
+
[[Category:FDA approved in 1989]]

Revision as of 19:27, 23 June 2024

General information

Class/mechanism: Antifungal, known to have activity against Pneumocystis jiroveci. Mechanism not fully understood, but mechanism hypothesized to involve inhibition of DNA, RNA, phospholipid, and protein synthesis.[1][2]
Route: inhaled, IM, IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

Also known as

  • Generic name: pentamidine dimesilate
  • Brand names: Benambax, Lomidine, Nebupent, Pentam, Pentamidina, Pneumopent

References